These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi. Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719 [TBL] [Abstract][Full Text] [Related]
8. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi. Gupta S; Garg NJ Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191 [TBL] [Abstract][Full Text] [Related]
9. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388 [TBL] [Abstract][Full Text] [Related]
10. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235 [TBL] [Abstract][Full Text] [Related]
11. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149 [TBL] [Abstract][Full Text] [Related]
12. Experimental Nanovaccine Offers Protection Against Repeat Exposures to Chowdhury IH; Lokugamage N; Garg NJ Front Immunol; 2020; 11():595039. PubMed ID: 33414785 [TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs. Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470 [TBL] [Abstract][Full Text] [Related]
16. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420 [TBL] [Abstract][Full Text] [Related]
18. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. Roffê E; Rothfuchs AG; Santiago HC; Marino AP; Ribeiro-Gomes FL; Eckhaus M; Antonelli LR; Murphy PM J Immunol; 2012 Jan; 188(2):649-60. PubMed ID: 22156594 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038 [TBL] [Abstract][Full Text] [Related]
20. IL-10 participates in the expansion and functional activation of CD8 Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]